US 12384779
Bicyclic compounds
granted A61KA61K45/06A61P
Quick answer
US patent 12384779 (Bicyclic compounds) held by Aligos Therapeutics, Inc. expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aligos Therapeutics, Inc.
- Grant date
- Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K45/06, A61P, A61P31/20